Intellia Therapeutics, Inc. (NTLA)
11.57
+0.15
(+1.31%)
USD |
NASDAQ |
Oct 19, 15:52
Intellia Therapeutics Market Cap : 1.620B for Oct. 19, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 1.599B |
| October 15, 2026 | 1.588B |
| October 14, 2026 | 1.600B |
| October 13, 2026 | 1.668B |
| October 12, 2026 | 1.761B |
| October 09, 2026 | 1.830B |
| October 08, 2026 | 1.764B |
| October 07, 2026 | 1.640B |
| October 06, 2026 | 1.732B |
| October 05, 2026 | 1.785B |
| October 02, 2026 | 1.717B |
| October 01, 2026 | 1.697B |
| September 30, 2026 | 1.689B |
| September 29, 2026 | 1.684B |
| September 28, 2026 | 1.599B |
| September 25, 2026 | 1.645B |
| September 24, 2026 | 1.703B |
| September 23, 2026 | 1.726B |
| September 22, 2026 | 1.777B |
| September 21, 2026 | 1.711B |
| September 18, 2026 | 1.700B |
| September 17, 2026 | 1.717B |
| September 16, 2026 | 1.609B |
| September 15, 2026 | 1.591B |
| September 14, 2026 | 1.662B |
| Date | Value |
|---|---|
| September 11, 2026 | 1.644B |
| September 10, 2026 | 1.670B |
| September 09, 2026 | 1.710B |
| September 08, 2026 | 1.784B |
| September 04, 2026 | 1.784B |
| September 03, 2026 | 1.775B |
| September 02, 2026 | 1.787B |
| September 01, 2026 | 1.776B |
| August 31, 2026 | 1.782B |
| August 28, 2026 | 1.802B |
| August 27, 2026 | 1.836B |
| August 26, 2026 | 1.847B |
| August 25, 2026 | 1.892B |
| August 24, 2026 | 1.759B |
| August 21, 2026 | 1.798B |
| August 20, 2026 | 1.742B |
| August 19, 2026 | 1.859B |
| August 18, 2026 | 1.624B |
| August 17, 2026 | 1.693B |
| August 14, 2026 | 1.668B |
| August 13, 2026 | 1.656B |
| August 12, 2026 | 1.693B |
| August 11, 2026 | 1.683B |
| August 10, 2026 | 1.683B |
| August 07, 2026 | 1.672B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 8.784B |
| Beam Therapeutics, Inc. | 2.491B |
| Prime Medicine, Inc. | 689.51M |
| 10X Genomics, Inc. | 9.092B |
| Moderna, Inc. | 90.70B |
Market Cap Related Metrics
| PS Ratio | 23.24 |
| Price to Book Value | 2.226 |
| Price | 11.57 |
| Earnings Yield | -29.01% |